Leveraging drug perturbation to reveal genetic regulators of hepatic gene expression in African Americans

Cookson, 2009, Mapping complex disease traits with global gene expression, Nat. Rev. Genet., 10, 184, 10.1038/nrg2537 Barreiro, 2012, Deciphering the genetic architecture of variation in the immune response to Mycobacterium tuberculosis infection, Proc. Natl. Acad. Sci. USA, 109, 1204, 10.1073/pnas.1115761109 Nédélec, 2016, Genetic ancestry and natural selection drive population differences in immune responses to pathogens, Cell, 167, 657, 10.1016/j.cell.2016.09.025 Kim-Hellmuth, 2017, Genetic regulatory effects modified by immune activation contribute to autoimmune disease associations, Nat. Commun., 8, 266, 10.1038/s41467-017-00366-1 Mangravite, 2013, A statin-dependent QTL for GATM expression is associated with statin-induced myopathy, Nature, 502, 377, 10.1038/nature12508 Knowles, 2018, Determining the genetic basis of anthracycline-cardiotoxicity by molecular response QTL mapping in induced cardiomyocytes, Elife, 7, e33480, 10.7554/eLife.33480 Jancova, 2010, Phase II drug metabolizing enzymes, Biomed. Pap. Med. Fac. Univ. Palacky Olomouc Czech. Repub., 154, 103, 10.5507/bp.2010.017 Zanger, 2013, Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation, Pharmacol. Ther., 138, 103, 10.1016/j.pharmthera.2012.12.007 Zhang, 2021, Variation in the expression of cytochrome P450-related miRNAs and transcriptional factors in human livers: Correlation with cytochrome P450 gene phenotypes, Toxicol. Appl. Pharmacol., 412, 115389, 10.1016/j.taap.2020.115389 de Leon, 2003, Adverse drug reactions to oxycodone and hydrocodone in CYP2D6 ultrarapid metabolizers, J. Clin. Psychopharmacol., 23, 420, 10.1097/01.jcp.0000085421.74359.60 Biswas, 2022, Effects of the CYP2C19 LoF allele on major adverse cardiovascular events associated with clopidogrel in acute coronary syndrome patients undergoing percutaneous coronary intervention: a meta-analysis, Pharmacogenomics, 23, 207, 10.2217/pgs-2021-0098 Relling, 2011, CPIC: clinical pharmacogenetics implementation consortium of the pharmacogenomics research network, Clin. Pharmacol. Ther., 89, 464, 10.1038/clpt.2010.279 Perera, 2013, Genetic variants associated with warfarin dose in African-American individuals: a genome-wide association study, Lancet, 382, 790, 10.1016/S0140-6736(13)60681-9 Prakash, 2015, Nuclear receptors in drug metabolism, drug response and drug interactions, Nucl. Receptor Res., 2, 101178, 10.11131/2015/101178 Shepherd, 2012, Adverse drug reaction deaths reported in United States vital statistics, 1999-2006, Ann. Pharmacother., 46, 169, 10.1345/aph.1P592 Zhong, 2020, Discovery of novel hepatocyte eQTLs in African Americans, PLoS Genet., 16, e1008662, 10.1371/journal.pgen.1008662 Gay, 2020, Impact of admixture and ancestry on eQTL analysis and GWAS colocalization in GTEx, Genome Biol., 21, 233, 10.1186/s13059-020-02113-0 Hendriks, 2020, Clinically relevant cytochrome P450 3A4 induction mechanisms and drug screening in three-dimensional spheroid cultures of primary human hepatocytes, Clin. Pharmacol. Ther., 108, 844, 10.1002/cpt.1860 Daujat, 1992, Omeprazole, an inducer of human CYP1A1 and 1A2, is not a ligand for the Ah receptor, Biochem. Biophys. Res. Commun., 188, 820, 10.1016/0006-291X(92)91130-I Hewitt, 2007, Primary hepatocytes: current understanding of the regulation of metabolic enzymes and transporter proteins, and pharmaceutical practice for the use of hepatocytes in metabolism, enzyme induction, transporter, clearance, and hepatotoxicity studies, Drug Metab. Rev., 39, 159, 10.1080/03602530601093489 Wagner, 2012, Measurement of mRNA abundance using RNA-seq data: RPKM measure is inconsistent among samples, Theor. Biosci., 131, 281, 10.1007/s12064-012-0162-3 Robinson, 2010, edgeR: a Bioconductor package for differential expression analysis of digital gene expression data, Bioinformatics, 26, 139, 10.1093/bioinformatics/btp616 Wettenhall, 2004, Linear models for microarray data user’s guide, Bioinformatics, 20, 3705, 10.1093/bioinformatics/bth449 Urbut, 2019, Flexible statistical methods for estimating and testing effects in genomic studies with multiple conditions, Nat. Genet., 51, 187, 10.1038/s41588-018-0268-8 Yu, 2012, clusterProfiler: an R package for comparing biological themes among gene clusters, OMICS A J. Integr. Biol., 16, 284, 10.1089/omi.2011.0118 Raudvere, 2019, g: Profiler: a web server for functional enrichment analysis and conversions of gene lists (2019 update), Nucleic Acids Res., 47, W191, 10.1093/nar/gkz369 Hoffman, 2016, variancePartition: interpreting drivers of variation in complex gene expression studies, BMC Bioinf., 17, 483, 10.1186/s12859-016-1323-z Sul, 2013, Effectively identifying eQTLs from multiple tissues by combining mixed model and meta-analytic approaches, PLoS Genet., 9, e1003491, 10.1371/journal.pgen.1003491 Han, 2011, Random-effects model aimed at discovering associations in meta-analysis of genome-wide association studies, Am. J. Hum. Genet., 88, 586, 10.1016/j.ajhg.2011.04.014 Stegle, 2012, Using probabilistic estimation of expression residuals (PEER) to obtain increased power and interpretability of gene expression analyses, Nat. Protoc., 7, 500, 10.1038/nprot.2011.457 Dabney, 2010 Leek, 2012, The sva package for removing batch effects and other unwanted variation in high-throughput experiments, Bioinformatics, 28, 882, 10.1093/bioinformatics/bts034 Welter, 2014, The NHGRI GWAS Catalog, a curated resource of SNP-trait associations, Nucleic Acids Res., 42, D1001, 10.1093/nar/gkt1229 Giambartolomei, 2014, Bayesian test for colocalisation between pairs of genetic association studies using summary statistics, PLoS Genet., 10, e1004383, 10.1371/journal.pgen.1004383 Yang, 2011, GCTA: a tool for genome-wide complex trait analysis, Am. J. Hum. Genet., 88, 76, 10.1016/j.ajhg.2010.11.011 Shen, 2009, Nrf2 plays an important role in coordinated regulation of Phase II drug metabolism enzymes and Phase III drug transporters, Biopharm. Drug Dispos., 30, 345, 10.1002/bdd.680 Martella, 2014, Secreted adiponectin as a marker to evaluate in vitro the adipogenic differentiation of human mesenchymal stromal cells, Cytotherapy, 16, 1476, 10.1016/j.jcyt.2014.05.005 Mimura, 2019, Kidney aging: an irresistible slope, Kidney Int., 95, 492, 10.1016/j.kint.2018.11.036 Bacos, 2016, Blood-based biomarkers of age-associated epigenetic changes in human islets associate with insulin secretion and diabetes, Nat. Commun., 7, 11089, 10.1038/ncomms11089 Lee, 2017, Comparative Interactomes of VRK1 and VRK3 with their distinct roles in the cell cycle of liver cancer, Mol. Cells, 40, 621 Hou, 2017, Omeprazole inhibits cell proliferation and induces G0/G1 cell cycle arrest through up-regulating miR-203a-3p expression in Barrett’s esophagus cells, Front. Pharmacol., 8, 968, 10.3389/fphar.2017.00968 Paz, 2020, Pharmacological Effects and Toxicogenetic Impacts of Omeprazole: Genomic Instability and Cancer, Oxid. Med. Cell. Longev., 2020, 10.1155/2020/3457890 Lin, 2011, Genetic variations in CYP17A1, CACNB2 and PLEKHA7 are associated with blood pressure and/or hypertension in She ethnic minority of China, Atherosclerosis, 219, 709, 10.1016/j.atherosclerosis.2011.09.006 Gong, 2021, PharmGKB, an Integrated Resource of Pharmacogenomic Knowledge, Curr. Protoc., 1, e226, 10.1002/cpz1.226 Mehanna, 2017, Blood pressure response to metoprolol and chlorthalidone in European and African Americans with hypertension, J. Clin. Hypertens., 19, 1301, 10.1111/jch.13094 Gong, 2016, Pharmacogenomic genome-wide meta-analysis of blood pressure response to beta-blockers in hypertensive African Americans, Hypertension, 67, 556, 10.1161/HYPERTENSIONAHA.115.06345 Liu, 2021, Expression of cytochrome P450 isozyme transcripts and activities in human livers, Xenobiotica, 51, 279, 10.1080/00498254.2020.1867929 Kranzler, 2021, A delta-opioid receptor gene polymorphism moderates the therapeutic response to extended-release buprenorphine in opioid use disorder, Int. J. Neuropsychopharmacol., 24, 89, 10.1093/ijnp/pyaa069 Samedy-Bates, 2019, Racial/ethnic-specific differences in the effects of inhaled corticosteroid use on bronchodilator response in patients with asthma, Clin. Pharmacol. Ther., 106, 1133, 10.1002/cpt.1555 2018, Diversifying clinical trials, Nat. Med., 24, 1779, 10.1038/s41591-018-0303-4 Deavall, 2012, Drug-induced oxidative stress and toxicity, J. Toxicol., 2012, 645460 Gong, 2006, Orphan nuclear receptor pregnane X receptor sensitizes oxidative stress responses in transgenic mice and cancerous cells, Mol. Endocrinol., 20, 279, 10.1210/me.2005-0205 Klotz, 2017, Cellular adaptation to xenobiotics: Interplay between xenosensors, reactive oxygen species and FOXO transcription factors, Redox Biol., 13, 646, 10.1016/j.redox.2017.07.015 Aleksunes, 2012, Coordinated regulation of hepatic phase I and II drug-metabolizing genes and transporters using AhR-CAR-PXR-PPARalpha-and Nrf2-null mice, Drug Metab. Dispos., 40, 1366, 10.1124/dmd.112.045112 Hasin, 2017, Multi-omics approaches to disease, Genome Biol., 18, 10.1186/s13059-017-1215-1 Pai, 2015, The genetic and mechanistic basis for variation in gene regulation, PLoS Genet., 11, e1004857, 10.1371/journal.pgen.1004857 Birdwell, 2015, Clinical pharmacogenetics implementation consortium (CPIC) guidelines for CYP3A5 genotype and tacrolimus dosing, Clin. Pharmacol. Ther., 98, 19, 10.1002/cpt.113 Liu, 2019, Genome-wide association study of tacrolimus pharmacokinetics identifies novel single nucleotide polymorphisms in the convalescence and stabilization periods of post-transplant liver function, Front. Genet., 10, 528, 10.3389/fgene.2019.00528